Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.

Engels EA, Pfeiffer RM, Landgren O, Moore RD.

J Acquir Immune Defic Syndr. 2010 May 1;54(1):78-84. doi: 10.1097/01.qai.0000371677.48743.8d.

PMID:
20418723
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.

Kirk O, Pedersen C, Cozzi-Lepri A, Antunes F, Miller V, Gatell JM, Katlama C, Lazzarin A, Skinhøj P, Barton SE; EuroSIDA Study Group.

Blood. 2001 Dec 1;98(12):3406-12.

PMID:
11719381
[PubMed - indexed for MEDLINE]
Free Article
3.

Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.

Bonnet F, Balestre E, Thiébaut R, Morlat P, Pellegrin JL, Neau D, Dabis F; Groupe d'Epidemiologie Clinique du SIDA en Aquitaine.

Clin Infect Dis. 2006 Feb 1;42(3):411-7. Epub 2005 Dec 27.

PMID:
16392091
[PubMed - indexed for MEDLINE]
Free Article
4.

Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.

Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, Furrer H, Hasse B, Levi F, Probst-Hensch NM, Schmid P, Franceschi S; Swiss HIV Cohort Study.

AIDS. 2008 Jan 11;22(2):301-6.

PMID:
18097233
[PubMed - indexed for MEDLINE]
5.

AIDS-related cancer and severity of immunosuppression in persons with AIDS.

Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA; HIV/AIDS Cancer Match Study.

J Natl Cancer Inst. 2007 Jun 20;99(12):962-72. Epub 2007 Jun 12.

PMID:
17565153
[PubMed - indexed for MEDLINE]
Free Article
6.

A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.

Bower M, Gazzard B, Mandalia S, Newsom-Davis T, Thirlwell C, Dhillon T, Young AM, Powles T, Gaya A, Nelson M, Stebbing J.

Ann Intern Med. 2005 Aug 16;143(4):265-73. Erratum in: Ann Intern Med. 2006 Apr 18;144(8):620.

PMID:
16103470
[PubMed - indexed for MEDLINE]
7.

Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).

Chow KU, Mitrou PS, Geduldig K, Helm EB, Hoelzer D, Brodt HR.

Leuk Lymphoma. 2001 Mar;41(1-2):105-16.

PMID:
11342362
[PubMed - indexed for MEDLINE]
8.

Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.

Robotin MC, Law MG, Milliken S, Goldstein D, Garsia RJ, Dolan GM, Kaldor JM, Grulich AE.

HIV Med. 2004 Sep;5(5):377-84.

PMID:
15369514
[PubMed - indexed for MEDLINE]
9.

Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.

Zoufaly A, Stellbrink HJ, Heiden MA, Kollan C, Hoffmann C, van Lunzen J, Hamouda O; ClinSurv Study Group.

J Infect Dis. 2009 Jul 1;200(1):79-87. doi: 10.1086/599313.

PMID:
19476437
[PubMed - indexed for MEDLINE]
Free Article
10.

Assessment of immunovirological features in HIV related non-Hodgkin lymphoma patients and their impact on outcome.

Tedeschi R, Bortolin MT, Bidoli E, Zanussi S, Pratesi C, Vaccher E, Tirelli U, De Paoli P.

J Clin Virol. 2012 Apr;53(4):297-301. doi: 10.1016/j.jcv.2011.12.021. Epub 2012 Jan 11.

PMID:
22244256
[PubMed - indexed for MEDLINE]
11.

Cancer risk in people infected with human immunodeficiency virus in the United States.

Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ.

Int J Cancer. 2008 Jul 1;123(1):187-94. doi: 10.1002/ijc.23487.

PMID:
18435450
[PubMed - indexed for MEDLINE]
12.

Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma.

Tam HK, Zhang ZF, Jacobson LP, Margolick JB, Chmiel JS, Rinaldo C, Detels R.

Int J Cancer. 2002 Apr 20;98(6):916-22.

PMID:
11948473
[PubMed - indexed for MEDLINE]
13.

Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma.

Stebbing J, Gazzard B, Mandalia S, Teague A, Waterston A, Marvin V, Nelson M, Bower M.

J Clin Oncol. 2004 Jun 1;22(11):2177-83.

PMID:
15169806
[PubMed - indexed for MEDLINE]
14.

The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.

Vilchez RA, Finch CJ, Jorgensen JL, Butel JS.

Medicine (Baltimore). 2003 Mar;82(2):77-81.

PMID:
12640183
[PubMed - indexed for MEDLINE]
15.

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.

Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L, Henry DH.

J Natl Cancer Inst. 1997 Feb 19;89(4):301-7.

PMID:
9048834
[PubMed - indexed for MEDLINE]
Free Article
16.

The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.

Anastos K, Barrón Y, Cohen MH, Greenblatt RM, Minkoff H, Levine A, Young M, Gange SJ.

Ann Intern Med. 2004 Feb 17;140(4):256-64.

PMID:
14970148
[PubMed - indexed for MEDLINE]
17.

Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.

Gandhi T, Wei W, Amin K, Kazanjian P.

Clin Infect Dis. 2006 Mar 15;42(6):878-84. Epub 2006 Feb 8.

PMID:
16477568
[PubMed - indexed for MEDLINE]
Free Article
18.

Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.

Seaberg EC, Wiley D, Martínez-Maza O, Chmiel JS, Kingsley L, Tang Y, Margolick JB, Jacobson LP; Multicenter AIDS Cohort Study (MACS).

Cancer. 2010 Dec 1;116(23):5507-16. doi: 10.1002/cncr.25530. Epub 2010 Jul 29.

PMID:
20672354
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.

Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ, Gold J, Finlayson RJ, Cooper DA, Kaldor JM.

AIDS. 2000 Jan 28;14(2):133-40.

PMID:
10708283
[PubMed - indexed for MEDLINE]
20.

Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.

Vaccher E, Spina M, Talamini R, Zanetti M, di Gennaro G, Nasti G, Tavio M, Bernardi D, Simonelli C, Tirelli U.

Clin Infect Dis. 2003 Dec 1;37(11):1556-64. Epub 2003 Nov 6.

PMID:
14614680
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk